Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Journal of Hepatology

Volumn 51, Issue 6, 2009, Pages 1088-1090

  Chan, Henry Lik Yuen ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON; TELBIVUDINE; TENOFOVIR;

ANTIVIRAL THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG POTENCY; HEALTH CARE POLICY; HEPATITIS B; HONG KONG; HUMAN; INCOME; LETTER; PRIORITY JOURNAL; REIMBURSEMENT; TREATMENT INDICATION;

ANTIVIRAL AGENTS; DRUG COSTS; HEPATITIS B, CHRONIC; HONG KONG; HUMANS; REIMBURSEMENT MECHANISMS;

EID: 71849083438     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.09.019     Document Type: Letter

References (8)

1. Liaw Y.F. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 51 (2009) 403-410
2. Wong G.L.H., Wong V.W.S., Choi P.C.L., Chan A.W.H., Chim A.M.L., Yiu K.K.L., et al. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B. Clin Gastroenterol Hepatol 7 (2009) 227-233
3. Wong G.L.H., Wong V.W.S., Choi P.C.L., Chan A.W.H., Chim A.M.L., Yiu K.K.L., et al. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography. Am J Gastroenterol 103 (2008) 3071-3081
4. Chan H.L.Y., Leung N.W.Y., Hussain M., Wong M.L., and Lok A.S.F. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 31 (2000) 763-768
5. Liaw Y.F., Leung N., Kao J.H., Piratvisuth T., Gane E., Han K.H., et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2 (2008) 263-283
6. Lampertico P., Vigano M., Manenti E., Iavarone M., Lunghi G., and Colombo M. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatology 42 (2005) 1414-1419
7. Chan H.L.Y., Wong V.W.S., Tse C.H., Chim A.M.L., Chan H.Y., Wong G.L.H., et al. Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B. Aliment Pharmacol Ther 25 (2007) 891-898
8. Tsoi K.K.F., Lui Y.Y.N., Wong V.W.S., and Chan H.L.Y. Cost-effectiveness analysis of anti-viral treatment strategies based on the roadmap model in chronic hepatitis B virus (HBV) infection. Hepatol Int 3 (2009) 105